ArticleBiomedical journal2021

LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p.

Xin Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.